Results 231 to 240 of about 778,558 (294)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Brain drain or brain circulation? a perspective from Latin American scientists. [PDF]

open access: yesFront Res Metr Anal
Freire-Fierro A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy